| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0940-2993(99)80033-5 |
| P698 | PubMed publication ID | 10445409 |
| P2093 | author name string | A Breuer | |
| E Frei | |||
| C A Bieler | |||
| H H Schmeiser | |||
| M Stiborová | |||
| P2860 | cites work | Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs | Q28248709 |
| Mechanism of formation and structural characterization of DNA adducts derived from peroxidative activation of benzidine | Q42209031 | ||
| 32P-adduct assay: comparative recoveries of structurally diverse DNA adducts in the various enhancement procedures | Q42214916 | ||
| Studies on the metabolism of aristolochic acids I and II. | Q42220010 | ||
| The first identification of the benzenediazonium ion formation from a non-aminoazo dye, 1-phenylazo-2-hydroxynaphthalene (Sudan I) by microsomes of rat livers | Q43825488 | ||
| Mechanism of formation and 32P-postlabeling of DNA adducts derived from peroxidative activation of carcinogenic non-aminoazo dye 1-phenylazo-2-hydroxynaphthalene (Sudan I). | Q46494713 | ||
| Identification and mutagenicity of metabolites of aristolochic acid formed by rat liver. | Q50204413 | ||
| Mutagenicity of the two main components of commercially available carcinogenic aristolochic acid in Salmonella typhimurium. | Q50208536 | ||
| Nuclease P1-mediated enhancement of sensitivity of 32P-postlabeling test for structurally diverse DNA adducts. | Q54423710 | ||
| Comparison of DNA adduct formation by aristolochic acids in various in vitro activation systems by 32P-post-labelling: evidence for reductive activation by peroxidases | Q63253399 | ||
| 32P-post-labelling analysis of DNA adducts formed by aristolochic acid in tissues from patients with Chinese herbs nephropathy | Q63253400 | ||
| Cytochrome P-450 and Peroxidase Oxidize Detoxication Products of Carcinogenic Aristolochic Acids (Aristolactams) to Reactive Metabolites Binding to DNA in vitro | Q63253411 | ||
| Characterization of DNA adducts formed by aristolochic acids in the target organ (forestomach) of rats by 32P-postlabelling analysis using different chromatographic procedures | Q63253413 | ||
| Tumour induction in mice following exposure to aristolochic acid | Q67967425 | ||
| Comparison of 32P-postlabeling and high pressure liquid chromatographic analyses for 7,12-dimethylbenz[a]anthracene--DNA adducts | Q70383798 | ||
| The isolation and structural elucidation of novel derivatives of aristolochic acid from Aristolochia indica | Q72280170 | ||
| Seven aristololactams from Aristolochia argentina | Q104394049 | ||
| P433 | issue | 4-5 | |
| P304 | page(s) | 421-427 | |
| P577 | publication date | 1999-07-01 | |
| P1433 | published in | Experimental and Toxicologic Pathology | Q15724492 |
| P1476 | title | Aristolactam I a metabolite of aristolochic acid I upon activation forms an adduct found in DNA of patients with Chinese herbs nephropathy. | |
| P478 | volume | 51 |
| Q33422844 | 13C-NMR data of diterpenes isolated from Aristolochia Species |
| Q90565908 | Acrolein contributes to urothelial carcinomas in patients with chronic kidney disease |
| Q36667086 | Active Site Mutations as a Suitable Tool Contributing to Explain a Mechanism of Aristolochic Acid I Nitroreduction by Cytochromes P450 1A1, 1A2 and 1B1. |
| Q34166280 | Aristolochic acid and 'Chinese herbs nephropathy': a review of the evidence to date |
| Q43066522 | Aristolochic acid nephropathy revisited: a place for innate and adaptive immunity? |
| Q50955682 | Characterization and determination of six aristolochic acids and three aristololactams in medicinal plants and their preparations by high-performance liquid chromatography-photodiode array detection/electrospray ionization mass spectrometry. |
| Q26995515 | Chinese herbs containing aristolochic acid associated with renal failure and urothelial carcinoma: a review from epidemiologic observations to causal inference |
| Q43419102 | Comparative study of the contents of analogues of aristolochic acid in two kinds of Aristolochiae Fructus by high-performance liquid chromatography |
| Q34359592 | Contribution of biotransformation enzymes to the development of renal injury and urothelial cancer caused by aristolochic acid: urgent questions, difficult answers |
| Q36061821 | Drug bioactivation, covalent binding to target proteins and toxicity relevance |
| Q43715479 | Evidence for reductive activation of carcinogenic aristolochic acids by prostaglandin H synthase -- (32)P-postlabeling analysis of DNA adduct formation |
| Q54221497 | Glycine N-methyltransferase inhibits aristolochic acid nephropathy by increasing CYP3A44 and decreasing NQO1 expression in female mouse hepatocytes. |
| Q35606719 | Herbal bioactivation: the good, the bad and the ugly |
| Q41841343 | Identification of a reduction product of aristolochic acid: implications for the metabolic activation of carcinogenic aristolochic acid |
| Q38154957 | Knockout and humanized mice as suitable tools to identify enzymes metabolizing the human carcinogen aristolochic acid. |
| Q38671002 | Plant species forbidden in health food and their toxic constituents, toxicology and detoxification |
| Q41161072 | Predicting the possibility of two newly isolated phenetheren ring containing compounds from Aristolochia manshuriensis as CDK2 inhibitors |
| Q39985337 | Production, characterization of a monoclonal antibody against aristolochic acid-II and development of its assay system. |
| Q33224611 | Simultaneous determination of five aristolochic acids and two aristololactams in Aristolochia plants by high-performance liquid chromatography |
| Q40688546 | Synthesis and biological evaluation of aristolactams |
| Q44647136 | Transgene-derived hepatocyte growth factor attenuates reactive renal fibrosis in aristolochic acid nephrotoxicity |
Search more.